{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:15:33Z","timestamp":1788239733667,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05876-8","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:23:23Z","timestamp":1788236603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel dihydroisoxazole derivative DHI9 suppresses colorectal cancer cell survival by inducing oxidative stress, DNA damage, and mitochondrial apoptosis while targeting Akt and Wnt\/\u03b2-catenin signalling"],"prefix":"10.1007","author":[{"given":"Simona","family":"Zilakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Varcholova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Medvecova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Kudlickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2454-5799","authenticated-orcid":false,"given":"Martin","family":"Kello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"5876_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-026-05573-6","author":"A Al Mansoori","year":"2026","unstructured":"Al Mansoori A, Baig B, Harati R, Alhamidi RS, Hamza AA, Al-Salam S, Le A, Zhang C, Khare P, Hamoudi R, Amin A (2026) Safranal improves the anticancer efficacy of sorafenib via transcriptomic reprogramming and metabolomic changes in a rat model of diethylnitrosamine-induced cirrhosis-hepatocellular carcinoma. Naunyn-Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-026-05573-6","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"5876_CR2","doi-asserted-by":"publisher","first-page":"8311","DOI":"10.1021\/acs.jmedchem.9b01098","volume":"62","author":"JS Arya","year":"2019","unstructured":"Arya JS, Joseph MM, Sherin DR, Nair JB, Manojkumar TK, Maiti KK (2019) Exploring mitochondria-mediated intrinsic apoptosis by new phytochemical entities: an explicit observation of cytochrome c dynamics on lung and melanoma cancer cells. J Med Chem 62:8311\u20138329. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01098","journal-title":"J Med Chem"},{"key":"5876_CR3","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1016\/j.bmc.2015.07.069","volume":"23","author":"N Ashwini","year":"2015","unstructured":"Ashwini N, Garg M, Mohan CD, Fuchs JE, Rangappa S, Anusha S, Swaroop TR, Rakesh KS, Kanojia D, Madan V, Bender A, Koeffler HP, Basappa RKS (2015) Synthesis of 1,2-benzisoxazole tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and tubulin acetylation. Bioorg Med Chem 23:6157\u20136165. https:\/\/doi.org\/10.1016\/j.bmc.2015.07.069","journal-title":"Bioorg Med Chem"},{"key":"5876_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113336","author":"D Basak","year":"2020","unstructured":"Basak D, Uddin MN, Hancock J (2020) The role of oxidative stress and its counteractive utility in colorectal cancer (CRC). Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12113336","journal-title":"Cancers (Basel)"},{"key":"5876_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ph19030458","author":"S Bouabdallah","year":"2026","unstructured":"Bouabdallah S, Kouki A, Ibrahim MH, Brinza I, Boiangiu RS, Ben-Attia M, Hritcu L, Amin A (2026) Behavioral, biochemical, and in silico evidence for extraction-dependent neuroprotective effects of Citrus limon leaf essential oils in scopolamine-challenged zebrafish. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph19030458","journal-title":"Pharmaceuticals (Basel)"},{"key":"5876_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"5876_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-14-32","volume":"14","author":"M Brentnall","year":"2013","unstructured":"Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E, Boise LH (2013) Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol 14:32. https:\/\/doi.org\/10.1186\/1471-2121-14-32","journal-title":"BMC Cell Biol"},{"key":"5876_CR8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1080\/14756366.2018.1504041","volume":"33","author":"B Caliskan","year":"2018","unstructured":"Caliskan B, Sinoplu E, Ibis K, Akhan Guzelcan E, Cetin Atalay R, Banoglu E (2018) Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents. J Enzyme Inhib Med Chem 33:1352\u20131361. https:\/\/doi.org\/10.1080\/14756366.2018.1504041","journal-title":"J Enzyme Inhib Med Chem"},{"key":"5876_CR9","doi-asserted-by":"publisher","first-page":"50401","DOI":"10.18632\/oncotarget.10409","volume":"7","author":"YC Chen","year":"2016","unstructured":"Chen YC, Huang QL, Zhou H, Wang YP, Hu X, Li T (2016) Inhibition of canonical WNT\/\u03b2-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells. Oncotarget 7:50401\u201350416. https:\/\/doi.org\/10.18632\/oncotarget.10409","journal-title":"Oncotarget"},{"key":"5876_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63778-y","volume":"10","author":"B Cheng","year":"2020","unstructured":"Cheng B, Wang Q, Song Y, Liu Y, Liu Y, Yang S, Li D, Zhang Y, Zhu C (2020) MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo. Sci Rep 10:6741. https:\/\/doi.org\/10.1038\/s41598-020-63778-y","journal-title":"Sci Rep"},{"key":"5876_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13045-024-01617-7","volume":"17","author":"J Cortes","year":"2024","unstructured":"Cortes J (2024) Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD-positive AML. J Hematol Oncol 17:111. https:\/\/doi.org\/10.1186\/s13045-024-01617-7","journal-title":"J Hematol Oncol"},{"key":"5876_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.chemphyslip.2014.04.001","volume":"181","author":"K Cosentino","year":"2014","unstructured":"Cosentino K, Garcia-Saez AJ (2014) Mitochondrial alterations in apoptosis. Chem Phys Lipids 181:62\u201375. https:\/\/doi.org\/10.1016\/j.chemphyslip.2014.04.001","journal-title":"Chem Phys Lipids"},{"key":"5876_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2026.03.005","author":"C Cremolini","year":"2026","unstructured":"Cremolini C, Chalabi M, Elez E, Fassan M, Gelli M, Goere D, Modest DP, Montagut C, Osterlund P, Ricke J, Seligmann J, Taieb J, Yoshino T, Wyrwicz L, Ducreux M (2026) Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. https:\/\/doi.org\/10.1016\/j.annonc.2026.03.005","journal-title":"Ann Oncol"},{"key":"5876_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot087247","author":"LC Crowley","year":"2016","unstructured":"Crowley LC, Chojnowski G, Waterhouse NJ (2016) Measuring the DNA content of cells in apoptosis and at different cell-cycle stages by propidium iodide staining and flow cytometry. Cold Spring Harb Protoc. https:\/\/doi.org\/10.1101\/pdb.prot087247","journal-title":"Cold Spring Harb Protoc"},{"key":"5876_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88539-3","volume":"11","author":"JMC Danac","year":"2021","unstructured":"Danac JMC, Garcia RL (2021) CircPVT1 attenuates negative regulation of NRAS by let-7 and drives cancer cells towards oncogenicity. Sci Rep 11:9021. https:\/\/doi.org\/10.1038\/s41598-021-88539-3","journal-title":"Sci Rep"},{"key":"5876_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-20","volume":"5","author":"PM De Angelis","year":"2006","unstructured":"De Angelis PM, Svendsrud DH, Kravik KL, Stokke T (2006) Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer 5:20. https:\/\/doi.org\/10.1186\/1476-4598-5-20","journal-title":"Mol Cancer"},{"key":"5876_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2024.100203","author":"K Duan","year":"2024","unstructured":"Duan K, Tan F, Xie H, Liu H, Zhang Y, Jiang H, Wu W (2024) Design, synthesis and antitumor activity of 3,4,5-trisubstituted isoxazoles. Eur J Med Chem Rep. https:\/\/doi.org\/10.1016\/j.ejmcr.2024.100203","journal-title":"Eur J Med Chem Rep"},{"key":"5876_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jox16040120","author":"A Fahmy","year":"2026","unstructured":"Fahmy A, Hegab AMM, Mossalem HS, Abuzahrah SS, Alafghani SO, Hamza AA, Juaid N, Amin A (2026) Safranal enhances the efficacy of praziquantel against Schistosoma mansoni infection and alleviates liver fibrosis, inflammation and oxidative stress in mice. J Xenobiot. https:\/\/doi.org\/10.3390\/jox16040120","journal-title":"J Xenobiot"},{"key":"5876_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2022.107666","volume":"98","author":"M Fawzi","year":"2022","unstructured":"Fawzi M, Oubella A, Bimoussa A, Bamou FZ, Khdar ZA, Auhmani A, Riahi A, Robert A, Morjani H, Itto MYA (2022) Design, synthesis, evaluation of new 3-acetylisoxazolines and their hybrid analogous as anticancer agents: in vitro and in silico analysis. Comput Biol Chem 98:107666. https:\/\/doi.org\/10.1016\/j.compbiolchem.2022.107666","journal-title":"Comput Biol Chem"},{"key":"5876_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2022.2108690","volume":"23","author":"CD Fleming-de-Moraes","year":"2022","unstructured":"Fleming-de-Moraes CD, Rocha MR, Tessmann JW, de Araujo WM, Morgado-Diaz JA (2022) Crosstalk between PI3K\/Akt and Wnt\/\u03b2-catenin pathways promote colorectal cancer progression regardless of mutational status. Cancer Biol Ther 23:1\u201313. https:\/\/doi.org\/10.1080\/15384047.2022.2108690","journal-title":"Cancer Biol Ther"},{"key":"5876_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/md22070328","author":"SO Hassanin","year":"2024","unstructured":"Hassanin SO, Hegab AMM, Mekky RH, Said MA, Khalil MG, Hamza AA, Amin A (2024) Combining in vitro, in vivo, and network pharmacology assays to identify targets and molecular mechanisms of spirulina-derived biomolecules against breast cancer. Mar Drugs. https:\/\/doi.org\/10.3390\/md22070328","journal-title":"Mar Drugs"},{"key":"5876_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116397","volume":"271","author":"M Hawash","year":"2024","unstructured":"Hawash M, Abdallah S, Abudayyak M, Melhem Y, Abu Shamat M, Aghbar M, Capan I, Abualhasan M, Kumar A, Kaminski M, Goral T, Dominiak PM, Sobuh S (2024) Exploration of isoxazole analogs: synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling. Eur J Med Chem 271:116397. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116397","journal-title":"Eur J Med Chem"},{"key":"5876_CR23","doi-asserted-by":"publisher","first-page":"1528978","DOI":"10.3389\/fphar.2025.1528978","volume":"16","author":"R Ismail","year":"2025","unstructured":"Ismail R, Habib HA, Anter AF, Amin A, Heeba GH (2025) Modified citrus pectin ameliorates methotrexate-induced hepatic and pulmonary toxicity: role of Nrf2, galectin-3\/TLR-4\/NF-kappaB\/TNF-alpha and TGF-beta signaling pathways. Front Pharmacol 16:1528978. https:\/\/doi.org\/10.3389\/fphar.2025.1528978","journal-title":"Front Pharmacol"},{"key":"5876_CR24","doi-asserted-by":"publisher","unstructured":"Ji Y, Lv J, Sun D, Huang Y (2022) Therapeutic strategies targeting Wnt\/beta\u2011catenin signaling for colorectal cancer (Review). Int J Mol Med 49https:\/\/doi.org\/10.3892\/ijmm.2021.5056","DOI":"10.3892\/ijmm.2021.5056"},{"key":"5876_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/oncolo\/oyae037","volume":"29","author":"AC Johns","year":"2024","unstructured":"Johns AC, Campbell MT, Gao M, Hahn AW, Lim Z, Wang E, Gao J, Shah AY, Msaouel P, Tannir NM (2024) Efficacy, safety, and tolerability of tivozanib in heavily pretreated patients with advanced clear cell renal cell carcinoma. Oncologist 29:589\u2013595. https:\/\/doi.org\/10.1093\/oncolo\/oyae037","journal-title":"Oncologist"},{"key":"5876_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","volume":"42","author":"A Karimian","year":"2016","unstructured":"Karimian A, Ahmadi Y, Yousefi B (2016) Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst) 42:63\u201371. https:\/\/doi.org\/10.1016\/j.dnarep.2016.04.008","journal-title":"DNA Repair (Amst)"},{"key":"5876_CR27","doi-asserted-by":"publisher","unstructured":"Kauffman ME, Kauffman MK, Traore K, Zhu H, Trush MA, Jia Z, Li YR (2016) MitoSOX-based flow cytometry for detecting mitochondrial ROS. React Oxyg Species (Apex) 2: 361\u2013370. https:\/\/doi.org\/10.20455\/ros.2016.865","DOI":"10.20455\/ros.2016.865"},{"key":"5876_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00432-021-03888-w","volume":"148","author":"JC Kim","year":"2022","unstructured":"Kim JC, Bodmer WF (2022) Genomic landscape of colorectal carcinogenesis. J Cancer Res Clin Oncol 148:533\u2013545. https:\/\/doi.org\/10.1007\/s00432-021-03888-w","journal-title":"J Cancer Res Clin Oncol"},{"key":"5876_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111285","author":"NY Kim","year":"2024","unstructured":"Kim NY, Vishwanath D, Basappa S, Harish KK, Madegowda M, Rangappa KS, Basappa B, Ahn KS (2024) Isoxazole based nucleosides induce autophagy through the production of ROS and the suppression of the \u03b2-catenin pathway in human colorectal carcinoma cells. Chem Biol Interact. https:\/\/doi.org\/10.1016\/j.cbi.2024.111285","journal-title":"Chem Biol Interact"},{"key":"5876_CR30","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1039\/C4MD00279B","volume":"5","author":"RM Kumbhare","year":"2014","unstructured":"Kumbhare RM, Dadmal TL, Devi TA, Kumar D, Kosurkar UB, Chowdhury D, Appalanaidu K, Rao YK, Ramaiah MJ, Bhadra MP (2014) Isoxazole derivatives of 6-fluoro-N-(6-methoxybenzo[d]thiazol-2-yl)benzo[d]thiazol-2-amine and N-(pyrimidin-2-yl)benzo[d]thiazol-2-amine: regulation of cell cycle and apoptosis by p53 activation via mitochondrial-dependent pathways. Med Chem Commun 5:1744\u20131750. https:\/\/doi.org\/10.1039\/C4MD00279B","journal-title":"Med Chem Commun"},{"key":"5876_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3892\/or.2013.2851","volume":"31","author":"HH Lee","year":"2014","unstructured":"Lee HH, Ye S, Li XJ, Lee KB, Park MH, Kim SM (2014) Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt. Oncol Rep 31:183\u2013188. https:\/\/doi.org\/10.3892\/or.2013.2851","journal-title":"Oncol Rep"},{"key":"5876_CR32","volume":"25","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Kim WR, Park EG, Lee DH, Kim JM, Shin HJ, Jeong HS, Roh HY, Kim HS (2024) Exploring the key signaling pathways and ncRNAs in colorectal cancer. Int J Mol Sci 25:10.3390\/ijms25084548","journal-title":"Int J Mol Sci"},{"key":"5876_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-0716-2376-3_9","volume":"2508","author":"MB Lemieszek","year":"2022","unstructured":"Lemieszek MB, Findlay SD, Siegers GM (2022) Cell trace violet flow cytometric assay to assess cell proliferation. Methods Mol Biol 2508:101\u2013114. https:\/\/doi.org\/10.1007\/978-1-0716-2376-3_9","journal-title":"Methods Mol Biol"},{"key":"5876_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1289003","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Chu X, Yin Y, Li H, Fu H, Feng X, Deng Y, Ge J (2023) Design, synthesis, and evaluation of 4-(3-(3,5-dimethylisoxazol-4-yl)benzyl)phthalazin-1(2H)-one derivatives: potent BRD4 inhibitors with anti-breast cancer activity. Front Pharmacol 14:1289003. https:\/\/doi.org\/10.3389\/fphar.2023.1289003","journal-title":"Front Pharmacol"},{"key":"5876_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdc.2022.100907","author":"AK Lingala","year":"2022","unstructured":"Lingala AK, Mothe T, Murahari KK, Desireddi JR, Maiti B, Manchal R (2022) Design, synthesis and anticancer evaluation of isoxazole fused thiazole-oxazole derivatives. Chem Data Collect. https:\/\/doi.org\/10.1016\/j.cdc.2022.100907","journal-title":"Chem Data Collect"},{"key":"5876_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.938471","volume":"13","author":"L Lozon","year":"2022","unstructured":"Lozon L, Saleh E, Menon V, Ramadan WS, Amin A, El-Awady R (2022) Effect of safranal on the response of cancer cells to topoisomerase I inhibitors: does sequence matter? Front Pharmacol 13:938471. https:\/\/doi.org\/10.3389\/fphar.2022.938471","journal-title":"Front Pharmacol"},{"key":"5876_CR37","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1021\/acsptsci.5c00103","volume":"8","author":"M Majirska","year":"2025","unstructured":"Majirska M, Kudlickova Z, Nosalova N, Kello M, Michalkova R, Sabolova D, Tvrdonova M, Jager D, Pilatova MB, Vojtek M, Diniz C (2025) Discovery of anticancer indole-based 4,5-dihydroisoxazole derivative with selectivity toward leukemia cells. ACS Pharmacol Transl Sci 8:2507\u20132525. https:\/\/doi.org\/10.1021\/acsptsci.5c00103","journal-title":"ACS Pharmacol Transl Sci"},{"key":"5876_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030738","author":"M Mancini","year":"2022","unstructured":"Mancini M, Monaldi C, De Santis S, Rondoni M, Papayannidis C, Sartor C, Curti A, Bruno S, Cavo M, Soverini S (2022) Combined inhibition of polo-like kinase-1 and Wee1 as a new therapeutic strategy to induce apoptotic cell death in neoplastic mast cells. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14030738","journal-title":"Cancers (Basel)"},{"key":"5876_CR39","doi-asserted-by":"publisher","first-page":"8213","DOI":"10.1039\/D4RA08339C","volume":"15","author":"GJ Martis","year":"2025","unstructured":"Martis GJ, Gaonkar SL (2025) Advances in isoxazole chemistry and their role in drug discovery. RSC Adv 15:8213\u20138243. https:\/\/doi.org\/10.1039\/D4RA08339C","journal-title":"RSC Adv"},{"key":"5876_CR40","doi-asserted-by":"publisher","first-page":"5 1 1","DOI":"10.1002\/cpim.40","volume":"120","author":"KM McKinnon","year":"2018","unstructured":"McKinnon KM (2018) Flow cytometry: an overview. Curr Protoc Immunol 120:5 1 1-5 1 11. https:\/\/doi.org\/10.1002\/cpim.40","journal-title":"Curr Protoc Immunol"},{"key":"5876_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020248","author":"AM Mohmmed Hegab","year":"2025","unstructured":"Mohmmed Hegab AM, Hassanin SO, Mekky RH, Abuzahrah SS, Hamza AA, Talaat IM, Amin A (2025) Withania somnifera ameliorates doxorubicin-induced nephrotoxicity and potentiates its therapeutic efficacy targeting SIRT1\/Nrf2, oxidative stress, inflammation, and apoptosis. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph18020248","journal-title":"Pharmaceuticals (Basel)"},{"key":"5876_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29143246","author":"GK Mukusheva","year":"2024","unstructured":"Mukusheva GK, Jalmakhanbetova RI, Shaibek AZ, Nurmaganbetova MS, Zhasymbekova AR, Nurkenov OA, Akishina EA, Kolesnik IA, Dikusar EA, Terpinskaya TI, Kulchitsky VA, Potkin VI, Pushkarchuk AL, Lyakhov DA, Michels DL (2024) Alkaloid-based isoxazolylureas: synthesis and effect in combination with anticancer drugs on C6 rat glioma model cells. Molecules. https:\/\/doi.org\/10.3390\/molecules29143246","journal-title":"Molecules"},{"key":"5876_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.gastro.2019.08.059","volume":"158","author":"LH Nguyen","year":"2020","unstructured":"Nguyen LH, Goel A, Chung DC (2020) Pathways of colorectal carcinogenesis. Gastroenterology 158:291\u2013302. https:\/\/doi.org\/10.1053\/j.gastro.2019.08.059","journal-title":"Gastroenterology"},{"key":"5876_CR44","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1039\/d5md00339c","volume":"16","author":"P Pattanayak","year":"2025","unstructured":"Pattanayak P, Nikhitha S, Halder D, Ghosh B, Chatterjee T (2025) 5-(Thiophen-2-yl)isoxazoles as novel anti-breast cancer agents targeting ERalpha: synthesis, in vitro biological evaluation, in silico studies, and molecular dynamics simulation. RSC Med Chem 16:4355\u20134376. https:\/\/doi.org\/10.1039\/d5md00339c","journal-title":"RSC Med Chem"},{"key":"5876_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.70031","volume":"358","author":"M Perina","year":"2025","unstructured":"Perina M, Kiss MA, Belicek J, Vojackova V, Vesela D, Minorics R, Zupko I, Frank E, Jorda R (2025) Isoxazole-based compounds targeting the taxane-binding site of tubulin. Arch Pharm (Weinheim) 358:e70031. https:\/\/doi.org\/10.1002\/ardp.70031","journal-title":"Arch Pharm (Weinheim)"},{"key":"5876_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116663","volume":"175","author":"KS Prabhu","year":"2024","unstructured":"Prabhu KS, Kuttikrishnan S, Ahmad N, Habeeba U, Mariyam Z, Suleman M, Bhat AA, Uddin S (2024) H2AX: a key player in DNA damage response and a promising target for cancer therapy. Biomed Pharmacother 175:116663. https:\/\/doi.org\/10.1016\/j.biopha.2024.116663","journal-title":"Biomed Pharmacother"},{"key":"5876_CR47","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1039\/C4MD00525B","volume":"6","author":"SK Prajapti","year":"2015","unstructured":"Prajapti SK, Shrivastava S, Bihade U, Gupta AK, Naidu VGM, Banerjee UC, Babu BN (2015) Synthesis and biological evaluation of novel \u03942-isoxazoline fused cyclopentane derivatives as potential antimicrobial and anticancer agents. Med Chem Commun 6:839\u2013845. https:\/\/doi.org\/10.1039\/C4MD00525B","journal-title":"Med Chem Commun"},{"key":"5876_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10495-020-01601-9","volume":"25","author":"P Ramesh","year":"2020","unstructured":"Ramesh P, Medema JP (2020) BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy. Apoptosis 25:305\u2013320. https:\/\/doi.org\/10.1007\/s10495-020-01601-9","journal-title":"Apoptosis"},{"issue":"2","key":"5876_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/1097-0320(20011001)45:2<151::AID-CYTO1157>3.0.CO;2-I","volume":"45","author":"A Rasola","year":"2001","unstructured":"Rasola A, Geuna M (2001) A flow cytometry assay simultaneously detects independent apoptotic parameters. Cytometry A 45(2):151\u2013157.","journal-title":"Cytometry A"},{"key":"5876_CR50","unstructured":"Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, Minor L (2004) Cell Viability Assays. In: Markossian S, Grossman A, Baskir H, Arkin M, Auld D, Austin C, Baell J, Brimacombe K, Chung TDY, Coussens NP, Dahlin JL, Devanarayan V, Foley TL, Glicksman M, Gorshkov K, Grotegut S, Hall MD, Hoare S, Inglese J, Iversen PW, Lal-Nag M, Li Z, Manro JR, McGee J, Norvil A, Pearson M, Riss T, Saradjian P, Sittampalam GS, Tarselli MA, Trask OJ, Jr., Weidner JR, Wildey MJ, Wilson K, Xia M, Xu X (eds.) Assay guidance manual. Bethesda (MD)"},{"key":"5876_CR51","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1007\/s11696-021-01775-9","volume":"75","author":"FC Rodrigues","year":"2021","unstructured":"Rodrigues FC, Kumar NVA, Hari G, Pai KSR, Thakur G (2021) The inhibitory potency of isoxazole-curcumin analogue for the management of breast cancer: a comparative in vitro and molecular modeling investigation. Chem Pap 75:5995\u20136008. https:\/\/doi.org\/10.1007\/s11696-021-01775-9","journal-title":"Chem Pap"},{"key":"5876_CR52","doi-asserted-by":"publisher","unstructured":"Rozman Antolikova N, Kello M, Zigova M, Tischlerova V, Petrilla V, Pirnik Z, Mojzisova G, Mojzis J (2019) Naja ashei venom induces mitochondria-mediated apoptosis in human colorectal cancer cells. Acta Biochim Pol 66: 207\u2013213. https:\/\/doi.org\/10.18388\/abp.2018_2779","DOI":"10.18388\/abp.2018_2779"},{"key":"5876_CR53","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/sj.leu.2402090","volume":"15","author":"PP Ruvolo","year":"2001","unstructured":"Ruvolo PP, Deng X, May WS (2001) Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia 15:515\u2013522. https:\/\/doi.org\/10.1038\/sj.leu.2402090","journal-title":"Leukemia"},{"key":"5876_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41420-025-02391-2","volume":"11","author":"S Sabirova","year":"2025","unstructured":"Sabirova S, Sharapova G, Budyukova A, Gomzikova M, Brichkina A, Barlev NA, Rizvanov A, Markov N, Simon HU (2025) Comprehensive analysis of cellular metrics: from proliferation to mitochondrial membrane potential and cell death in a single sample. Cell Death Discov 11:119.","journal-title":"Cell Death Discov"},{"key":"5876_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6769-12-5","volume":"12","author":"MP Sadashiva","year":"2012","unstructured":"Sadashiva MP, Basappa NS, Li F, Manu KA, Sengottuvelan M, Prasanna DS, Anilkumar NC, Sethi G, Sugahara K, Rangappa KS (2012) Anti-cancer activity of novel dibenzo[b,f]azepine tethered isoxazoline derivatives. BMC Chem Biol 12:5. https:\/\/doi.org\/10.1186\/1472-6769-12-5","journal-title":"BMC Chem Biol"},{"key":"5876_CR56","doi-asserted-by":"publisher","unstructured":"Sawicki T, Ruszkowska M, Danielewicz A, Niedzwiedzka E, Arlukowicz T, Przybylowicz KE (2021) A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel) 13https:\/\/doi.org\/10.3390\/cancers13092025","DOI":"10.3390\/cancers13092025"},{"key":"5876_CR57","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1039\/d5md00554j","volume":"17","author":"Y Sheng","year":"2025","unstructured":"Sheng Y, Wu B, Li F, Zhang C (2025) Design, synthesis, and biological evaluation of procaine-based triazole-isoxazoline hybrids as selective PI3K\/mTOR inhibitors for esophageal cancer therapy: in vitro and in vivo studies. RSC Med Chem 17:286\u2013309. https:\/\/doi.org\/10.1039\/d5md00554j","journal-title":"RSC Med Chem"},{"key":"5876_CR58","doi-asserted-by":"publisher","unstructured":"Shimura T (2023) Mitochondrial signaling pathways associated with DNA onses. Int J Mol Sci 24https:\/\/doi.org\/10.3390\/ijms24076128","DOI":"10.3390\/ijms24076128"},{"key":"5876_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/biom12070904","author":"G Spinozzi","year":"2022","unstructured":"Spinozzi G, Tini V, Ferrari A, Gionfriddo I, Ranieri R, Milano F, Pierangeli S, Donnini S, Mezzasoma F, Silvestri S, Falini B, Martelli MP (2022) SiCoDEA: a simple, fast and complete app for analyzing the effect of individual drugs and their combinations. Biomolecules. https:\/\/doi.org\/10.3390\/biom12070904","journal-title":"Biomolecules"},{"key":"5876_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111143","volume":"399","author":"RN Suresh","year":"2024","unstructured":"Suresh RN, Jung YY, Harsha KB, Mohan CD, Ahn KS, Rangappa KS (2024) Isoxazolyl-urea derivative evokes apoptosis and paraptosis by abrogating the Wnt\/beta-catenin axis in colon cancer cells. Chem Biol Interact 399:111143. https:\/\/doi.org\/10.1016\/j.cbi.2024.111143","journal-title":"Chem Biol Interact"},{"key":"5876_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104710","volume":"211","author":"K Thangaretnam","year":"2025","unstructured":"Thangaretnam K, Islam MO, Lv J, El-Rifai A, Perloff A, Soutto HL, Peng D, Chen Z (2025) WEE1 inhibition in cancer therapy: mechanisms, synergies, preclinical insights, and clinical trials. Crit Rev Oncol Hematol 211:104710. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104710","journal-title":"Crit Rev Oncol Hematol"},{"key":"5876_CR62","doi-asserted-by":"publisher","DOI":"10.3791\/57691","author":"M Vang Mouritzen","year":"2018","unstructured":"Vang Mouritzen M, Jenssen H (2018) Optimized scratch assay for in vitro testing of cell migration with an automated optical camera. J vis Exp. https:\/\/doi.org\/10.3791\/57691","journal-title":"J vis Exp"},{"key":"5876_CR63","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ygyno.2019.09.021","volume":"156","author":"JT Veneris","year":"2020","unstructured":"Veneris JT, Matulonis UA, Liu JF, Konstantinopoulos PA (2020) Choosing wisely: selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations. Gynecol Oncol 156:488\u2013497. https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.021","journal-title":"Gynecol Oncol"},{"key":"5876_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24122335","author":"H Wang","year":"2019","unstructured":"Wang H, Ma Y, Lin Y, Liu J, Chen R, Xu B, Liang Y (2019) An isoxazole derivative SHU00238 suppresses colorectal cancer growth through miRNAs regulation. Molecules. https:\/\/doi.org\/10.3390\/molecules24122335","journal-title":"Molecules"},{"key":"5876_CR65","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/fft2.151","volume":"3","author":"F Wang","year":"2022","unstructured":"Wang F, Yang G, Song H, Xiong L, Wang L, Shen X (2022) The guideline for western blotting assay. Food Front 3:347\u2013349. https:\/\/doi.org\/10.1002\/fft2.151","journal-title":"Food Front"},{"key":"5876_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106505","volume":"135","author":"M Wang","year":"2023","unstructured":"Wang M, Li L, Yang S, Guo F, Zhu G, Zhu B, Chang J (2023) Synthesis of novel oxazol-5-one derivatives containing chiral trifluoromethyl and isoxazole moieties as potent antitumor agents and the mechanism investigation. Bioorg Chem 135:106505. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106505","journal-title":"Bioorg Chem"},{"key":"5876_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115674","volume":"28","author":"ET Warda","year":"2020","unstructured":"Warda ET, Shehata IA, El-Ashmawy MB, El-Gohary NS (2020) New series of isoxazole derivatives targeting EGFR-TK: synthesis, molecular modeling and antitumor evaluation. Bioorg Med Chem 28:115674. https:\/\/doi.org\/10.1016\/j.bmc.2020.115674","journal-title":"Bioorg Med Chem"},{"key":"5876_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0116-z","volume":"5","author":"YH Xie","year":"2020","unstructured":"Xie YH, Chen YX, Fang JY (2020) Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther 5:22. https:\/\/doi.org\/10.1038\/s41392-020-0116-z","journal-title":"Signal Transduct Target Ther"},{"key":"5876_CR69","doi-asserted-by":"publisher","unstructured":"Yin L, Niu C, Liao LX, Dou J, Habasi M, Aisa HA (2017) An isoxazole chalcone derivative enhances melanogenesis in B16 melanoma cells via the Akt\/GSK3beta\/beta-catenin signaling pathways. Molecules 22https:\/\/doi.org\/10.3390\/molecules22122077","DOI":"10.3390\/molecules22122077"},{"key":"5876_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116448","volume":"272","author":"L Zhang","year":"2024","unstructured":"Zhang L, Liu P, Jiang Y, Fan D, He X, Zhang J, Luo B, Sui J, Luo Y, Fu X, Yang T (2024) Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level. Eur J Med Chem 272:116448. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116448","journal-title":"Eur J Med Chem"},{"key":"5876_CR71","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1016\/j.bmc.2018.05.013","volume":"26","author":"J Zhu","year":"2018","unstructured":"Zhu J, Mo J, Lin H-z, Chen Y, Sun H-p (2018) The recent progress of isoxazole in medicinal chemistry. Bioorg Med Chem 26:3065\u20133075. https:\/\/doi.org\/10.1016\/j.bmc.2018.05.013","journal-title":"Bioorg Med Chem"},{"key":"5876_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02890-3","volume":"42","author":"S Zilakova","year":"2025","unstructured":"Zilakova S, Gavurova M, Sebova D, Goga M, Backor M, Medvecova V, Kecsey D, Kello M (2025) Nostoc commune-derived scytonemin induced mitochondrial cell death in leukemia models. Med Oncol 42:341. https:\/\/doi.org\/10.1007\/s12032-025-02890-3","journal-title":"Med Oncol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05876-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05876-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05876-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:23:27Z","timestamp":1788236607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05876-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":72,"alternative-id":["5876"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05876-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"14 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}